Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Clinical trial NCT04643093 · COMPLETED
Trial details
- NCT number
- NCT04643093
- Sponsor
- Orient Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-08-19
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.